Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuya Inomata

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|March 20, 2026
Longitudinal Biometric Changes and Intraocular Lens Calculation Formula Accuracy in Delayed Cataract Surgery CasesShohei Nishida, Akira Hirata, Yasuya Inomata
Clinical Ophthalmology (Auckland, N.Z.)|August 19, 2024
Risk Factors for Postoperative Refractive Error in New-Generation Intraocular Lens Calculation FormulasShohei Nishida, Yasuya Inomata, Akira Hirata
American Journal of Ophthalmology|July 31, 2003
Persistent subretinal indocyanine green induces retinal pigment epithelium atrophyAkira Hirata, Yasuya Inomata, Takahiro Kawaji, et al.
Investigative Ophthalmology & Visual Science|May 27, 2016
Differentiated Expression Patterns and Phagocytic Activities of Type 1 and 2 MicrogliaAkira Haga, Eri Takahashi, Yasuya Inomata, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 15, 2004
Morphological damage in rabbit retina caused by subretinal injection of indocyanine greenTakahiro Kawaji, Akira Hirata, Yasuya Inomata, et al.
Acta Ophthalmologica|December 9, 2017
Treat-and-extend versus every-other-month regimens with aflibercept in age-related macular degenerationAkira Haga, Takahiro Kawaji, Ryuichi Ideta, et al.
Neuroreport|April 10, 2004
Elevated erythropoietin in vitreous with ischemic retinal diseasesYasuya Inomata, Akira Hirata, Eri Takahashi, et al.
Retina (Philadelphia, Pa.)|November 28, 2007
Plasmin-assisted vitrectomy for management of proliferative membrane in proliferative diabetic retinopathy: a pilot studyAkira Hirata, Akiomi Takano, Yasuya Inomata, et al.
Biochemical and Biophysical Research Communications|February 27, 2003
Neuroprotective effects of interleukin-6 on NMDA-induced rat retinal damageYasuya Inomata, Akira Hirata, Naoko Yonemura, et al.
Japanese Journal of Ophthalmology|April 20, 2005
Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseasesShinji Yoneda, Hideaki Hara, Akira Hirata, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical Ophthalmology (Auckland, N.Z.)|March 20, 2026
Longitudinal Biometric Changes and Intraocular Lens Calculation Formula Accuracy in Delayed Cataract Surgery CasesShohei Nishida, Akira Hirata, Yasuya Inomata
Clinical Ophthalmology (Auckland, N.Z.)|August 19, 2024
Risk Factors for Postoperative Refractive Error in New-Generation Intraocular Lens Calculation FormulasShohei Nishida, Yasuya Inomata, Akira Hirata
American Journal of Ophthalmology|July 31, 2003
Persistent subretinal indocyanine green induces retinal pigment epithelium atrophyAkira Hirata, Yasuya Inomata, Takahiro Kawaji, et al.
Investigative Ophthalmology & Visual Science|May 27, 2016
Differentiated Expression Patterns and Phagocytic Activities of Type 1 and 2 MicrogliaAkira Haga, Eri Takahashi, Yasuya Inomata, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 15, 2004
Morphological damage in rabbit retina caused by subretinal injection of indocyanine greenTakahiro Kawaji, Akira Hirata, Yasuya Inomata, et al.
Acta Ophthalmologica|December 9, 2017
Treat-and-extend versus every-other-month regimens with aflibercept in age-related macular degenerationAkira Haga, Takahiro Kawaji, Ryuichi Ideta, et al.
Neuroreport|April 10, 2004
Elevated erythropoietin in vitreous with ischemic retinal diseasesYasuya Inomata, Akira Hirata, Eri Takahashi, et al.
Retina (Philadelphia, Pa.)|November 28, 2007
Plasmin-assisted vitrectomy for management of proliferative membrane in proliferative diabetic retinopathy: a pilot studyAkira Hirata, Akiomi Takano, Yasuya Inomata, et al.
Biochemical and Biophysical Research Communications|February 27, 2003
Neuroprotective effects of interleukin-6 on NMDA-induced rat retinal damageYasuya Inomata, Akira Hirata, Naoko Yonemura, et al.
Japanese Journal of Ophthalmology|April 20, 2005
Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseasesShinji Yoneda, Hideaki Hara, Akira Hirata, et al.
Pageof 3